Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bevacizumab with allogeneic hematopoietic stem cell transplantation for advanced solid tumors, including breast and ovarian cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer, Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-01-28